References
- Carroll K M, Power M E, Bryant K, Rounsaville B J. One‐year follow‐up status of treatment‐seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis 1993; 181: 71–79
- McMahon R C, Kouzekanani K, Malow R M. A comparative study of cocaine‐treatment completers and dropouts. J Subst Abuse Treat 1999; 16: 17–22
- Moeller F G, Dougherty D M, Barratt E S, Schmitz J M, Swann A C, Grabowski J. The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat 2001; 21: 193–198
- Siqueland L, Crits‐Christoph P, Gallop R, Barber J P, Griffin M L, Thase M E, Daley D, Frank A, Gastfriend D R, Blaine J, Connolly M B, Gladis M. Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am J Addict 2002; 11: 24–40
- Carroll K M, Rounsaville B J, Nich C, Gordon L T, Wirtz P W, Gawin F. One‐year follow‐up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994; 51: 989–997
- Reiber C, Ramirez A, Parent D, Rawson R A. Predicting treatment success at multiple timepoints in diverse patient populations of cocaine‐dependent individuals. Drug Alcohol Depend 2002; 68: 35–48
- Alterman A I, McKay J R, Mulvaney F D, McLellan A T. Prediction of attrition from day hospital treatment in lower socioeconomic cocaine‐dependent men. Drug Alcohol Depend 1996; 40: 227–233
- Alterman A I, Kampman K, Boardman C R, Cacciola J S, Rutherford M J, McKay J R, Maany I. A cocaine‐positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug Alcohol Depend 1997; 46: 79–85
- Ehrman R N, Robbins S J, Cornish J W. Results of a baseline urine test predict levels of cocaine use during treatment. Drug Alcohol Depend 2001; 62: 1–7
- Kosten T, Poling J, Oliveto A. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine‐ and desipramine‐treated patients. Addiction 2003; 98(5)665–671
- Kosten T, Oliveto A, Feingold A, Sevarino K, McCance‐Katz E, Stine S, Gonzalez G, Gonsai K. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend 2003; 70(3)315–325
- First M B, Spitzer R L, Gibbon M, Williams J B. Structured Clinical Interview for DSM‐IV Axis I Disorders Patient Edition. Biometrics Research Department, New York State Psychiatric Institute, New York 1996
- McLellan A T, Luborsky L, Woody G E, O'Brien C P. An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. J Nerv Ment Dis 1980; 168: 26–33
- Radloff L S. The CES‐D scale: a self‐report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401
- Ling W, Shoptaw S, Wesson D, Rawson R A, Compton M, Klett C J. Treatment effectiveness score as an outcome measure in clinical trials. NIDA Res Monogr 1997; 175: 208–220
- Oliveto A H, Feingold A, Schottennfeld R, Jatlow P, Kosten T R. Desipramine in opioid‐dependent cocaine abusers mainatained on buprenorphine vs. methadone. Arch Gen Psychiatry 1999; 56: 812–820
- Silverman K, Wong C J, Higgins S T, Brooner R K, Montoya I D, Contoreggi C, Umbricht‐Schneiter A, Schuster C R, Preston K L. Increasing opiate abstinence through voucher‐based reinforcement therapy. Drug Alcohol Depend 1996; 41: 157–165